Multiple Myeloma: Clinical Adoption of New Data Announcements

Recently announced advances in the treatment of Multiple Myeloma (MM), for both newly diagnosed and relapsed / refractory patients, have been quickly embraced by oncologists globally.

MDoutlook are pleased to share complimentary highlights from the most recent MDoutlook OncoPollâ„¢: Clinical Impact of Recent Data Announcements in the treatment of Multiple Myeloma. This research is based on an on-line survey of US and European oncologists actively managing MM patients. Access the highlights here. Copies of the full report are available upon request.

If you have any questions or feedback, or want to discuss how MDoutlook can provide deep, customized insight to your specific oncology needs, please let us know.